— Know what they know.
Not Investment Advice
Also trades as: NZYM-B.CO (CPH) · $vol 38M · NVZMY (OTC) · $vol 2M · NVZMF (OTC) · $vol 0M

NSIS-B.CO CPH

Novozymes A/S
1W: -2.0% 1M: -7.7% 3M: -2.9% YTD: +7.9% 1Y: -0.5% 3Y: +34.7% 5Y: -9.3%
kr 416.00 ($62.27)
+3.00 (+0.73%)
 
Weekly Expected Move ±3.2%
kr 390 kr 403 kr 416 kr 429 kr 442
CPH · Basic Materials · Chemicals - Specialty · Tech Score Sell · Power 36 · kr 194.0B mcap · 345M float · 0.169% daily turnover

Income Trends

Revenue
$4.2B +8.5% ▲
5Y CAGR: -21.6%
Gross Profit
$2.2B +23.9% ▲
5Y CAGR: -22.2%
Operating Income
$883M +33.9% ▲
5Y CAGR: -24.7%
Net Income
$584M +90.8% ▲
5Y CAGR: -27.1%
EPS (Diluted)
$9.33 +748.2% ▲
5Y CAGR: -1.4%
EBITDA
$19.0B +135.3% ▲
5Y CAGR: +31.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$15.0B$17.6B$17.9B$3.8B$4.2B
YoY Growth+6.7%+17.4%+2.0%-78.6%+8.5%
Cost of Revenue$6.3B$8.0B$8.2B$2.0B$1.9B
Gross Profit$1.2B$9.6B$9.7B$1.8B$2.2B
Gross Margin7.8%54.6%54.3%47.2%53.9%
R&D Expenses$2.0B$2.0B$2.0B$413M-$433M
SG&A Expenses$2.8B$3.2B$3.3B$766M$912M
Operating Expenses$4.7B$5.0B$5.7B$1.2B$1.4B
Operating Income$4.0B$4.6B$4.0B$659M$883M
Operating Margin26.8%26.4%22.2%17.2%21.2%
Interest Expense$102M$102M$23M$76M$68M
Income Before Tax$3.9B$4.6B$3.9B$417M$743M
Tax Expense$779M$870M$870M$111M$160M
Net Income$3.1B$3.7B$3.0B$306M$584M
Net Margin21.0%20.9%16.9%8.0%14.0%
EPS (Diluted)$11.23$13.19$1.46$1.10$9.33
EBITDA$5.4B$6.1B$5.5B$8.1B$19.0B
Shares Outstanding280M279M278M278M467M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms